Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
about
Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadPolarizing T and B Cell Responses by APC-Targeted Subunit VaccinesSingle-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.Comparative study of lymphocytes from individuals that were vaccinated and unvaccinated against the pandemic 2009-2011 H1N1 influenza virus in Southern Brazil.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.RIG-I ligand enhances the immunogenicity of recombinant H7HA proteinHuman Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceA De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in MiceProtective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining.PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A.Vaccine efficacy and T helper cell differentiation change with aging.Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.Roads to advanced vaccines: influenza case study.Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique.Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin.Aureobasidium pullulans-cultured fluid induces IL-18 production, leading to Th1-polarization during influenza A virus infection.Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins.Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?Universal influenza vaccines, science fiction or soon reality?The Global Influenza Surveillance and Response System (GISRS) - A Future Perspective.Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes.Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in miceAvian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentDevelopment of a novel clustering tool for linear peptide sequencesPolyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections
P2860
Q26783884-3905BDF7-E27F-494F-98A7-67ED9AD8C0D8Q26783897-0F5E8BA6-4746-42C2-9C8D-0C9FA5B43F8CQ26800145-F811DBD0-7A59-4CBC-BD11-CDC09118E855Q30376518-3D8E2D01-D713-4510-9B49-FEF68721A095Q30380824-BD21D833-4A69-4863-828F-CFDC76D1D723Q30381864-B94BB7A3-949D-4E35-86D6-96DEB0A8E1A5Q30382787-F59D43F0-57B1-4262-82D6-86482B394EFFQ30386346-7BB02F6C-3B76-4D9A-B78C-A14423D4002BQ30387227-D4333988-2D01-4A1C-9002-4DF27428CFAAQ30389743-8D0D14E3-A356-44DB-99E3-5C98B35B25F5Q30392456-62FC594E-ABD4-4211-A60B-37495B116E3FQ30395705-2431549E-1FE5-40F7-9B93-89D728B5B78FQ30397362-905C69FF-D5A6-4360-BD66-3E0E6F8E90D3Q36229655-4B57BCC2-8335-4630-AD2C-726E33DEFE2AQ36527796-0BE70683-E674-421D-AEA5-4B800A1CBB2EQ36950058-7ABFD453-68AC-4C0D-A69D-D8368E3F4823Q37194981-2B5D6645-D725-45E5-AEDB-891750A8CB01Q37237425-D7E945F0-5DD5-4D3E-B5E2-F6F6987D4E20Q37319033-D1CC824B-E9EA-4740-83CF-E5D297335776Q37376099-00F54F7D-F3D2-44F4-961D-96A4C7005014Q38436945-2551EF7B-B51D-4421-8B2F-EC289939A9AEQ38671897-EFB9B9BE-AA3B-4E87-A179-4FCF188BFE1EQ40092863-2D40AB81-6180-4F87-A039-4FB334919A30Q40139850-786BE1FC-74FB-4696-B49A-3E7EE0A1CC3AQ40541873-22BDF2D8-9396-432F-95A3-6FB172962BB0Q45324179-1B14BAEC-0FCB-48E4-9D71-5A7A569BA77FQ45324750-33B40A18-0110-4FCB-941F-D9D27E98FFEEQ45325937-1C751AD1-CE59-4114-9A9C-3331AD3F242BQ45326263-60D16E8A-C7E0-4C0B-A77B-80354F70C013Q47144502-7E9BDA6A-2448-44DF-A3CF-E4CDCDFF20E1Q47547355-45CE49F0-AB8A-4A22-89B2-03FC4410BA90Q47564262-ABE833CF-CD27-4AC3-909F-7C043830C5E2Q51003270-D12F360A-CF0C-4752-9AD9-5AB2D50C63A8Q54222152-3625DA79-9B79-4609-8EA4-C1DF2D91CD1EQ54239201-BB8FF4F5-738A-4D0C-829A-ED0AA007F386Q55114818-97636A6F-0975-4EE7-908F-4EEE1F51EBDFQ56221441-9C1BE70F-F122-4B41-883A-535EC9A43CC2Q56561344-642C3FD5-4F91-42AC-9B63-2C31CF4C066AQ56762923-5BD291D8-BF19-434E-94E3-3465946E9E68Q57167166-58ECC982-5334-4028-A773-7143CDD693A0
P2860
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@ast
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@en
type
label
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@ast
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@en
prefLabel
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@ast
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@en
P1433
P1476
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
@en
P2093
Arwen F Altenburg
Rory D de Vries
P304
P356
10.1016/J.VACCINE.2014.11.054
P407
P577
2014-12-09T00:00:00Z